Literature DB >> 3041926

Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation.

M Adler1, J S Gavaler, R Duquesnoy, J J Fung, G Svanas, T E Starzl, D H van Thiel.   

Abstract

The purpose of this study was to identify which of the biochemical, immunological, or functional parameters derived before surgery as part of a systemic evaluation were helpful in predicting the frequency of rejection episodes, the chance of survival, and the cause risk of death (should death occur) of patients after orthotopic liver transplantation (OLTx). Ninety-eight adult patients who had an extensive preoperative protocol evaluation were studied before OLTx. The biochemical parameters assessed were albumin, prothrombin time, bilirubin, and ICG clearance. The immunologic parameters assessed included total lymphocytes, T3 cells, T4 cells, T8 cells, and the T4/T8 ratio. The degree of histocompatibility antigen (HLA) matching between the donor and the recipient was also evaluated in 80 of the 98 patients studied. Most postoperative deaths occurred within 12 weeks of the procedure (24%; 24 of 98 patients); 13 patients (13%) died within the first 6 postoperative weeks, of either bacterial or fungal sepsis. An additional 14 patients (14%) died after the initial 6 postoperative weeks due, primarily of an acquired viral and/or protozoan infection (p less than 0.01). During the first 6 weeks, survival was better for patients with cholestatic liver disease (ChLD, 93%, n = 45) and miscellaneous liver diseases (MISC, 100%, n = 10) than it was for those with parenchymal liver diseases (PLD, 77%, n = 43). Although albumin, prothrombin time, T4/T8 ratios, and per cent T8 cells were statistically different in patients with PLD as compared with those with ChLD, these parameters, as well as the per cent T4 cells, serum bilirubin level, per cent retention of ICG at 15 minutes, and the plasma ICG disappearance rate were not found to be of substantial help in predicting patient survival or non-survival. Moreover, neither the degree of HLA matching nor the number of rejection episodes differed between surviving and nonsurviving patients. The results of this study suggest that patients with PLD are at increased risk of early postoperative death after OLTx because of bacterial and/or fungal sepsis, as compared with patients operated upon for ChLD. Better pre-, intra-, and postoperative predictors of risk of death and complications are needed to reduce the early mortality observed after orthotopic liver transplantation.

Entities:  

Mesh:

Year:  1988        PMID: 3041926      PMCID: PMC1493627          DOI: 10.1097/00000658-198808000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

1.  Liver disease and its effect on haemostasis during liver transplantation.

Authors:  E B Haagsma; C H Gips; H Wesenhagen; G W Van Imhoff; R A Krom
Journal:  Liver       Date:  1985-06

2.  Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis.

Authors:  T L Whiteside; S Lasky; L Si; D H Van Thiel
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

3.  Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment.

Authors:  G Opelz
Journal:  Transplantation       Date:  1985-09       Impact factor: 4.939

4.  T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.

Authors:  L Si; T L Whiteside; R R Schade; T E Starzl; D H Van Thiel
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

Review 5.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

Review 6.  Nutrition and host defense mechanisms.

Authors:  B D Kahan
Journal:  Surg Clin North Am       Date:  1981-06       Impact factor: 2.741

7.  Indications for liver transplantation in the cyclosporine era.

Authors:  R D Gordon; B W Shaw; S Iwatsuki; C O Esquivel; T E Starzl
Journal:  Surg Clin North Am       Date:  1986-06       Impact factor: 2.741

8.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

9.  The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation.

Authors:  F A Bontempo; J H Lewis; D H Van Thiel; J A Spero; M V Ragni; P Butler; L Israel; T E Starzl
Journal:  Transplantation       Date:  1985-05       Impact factor: 4.939

10.  Liver transplantation in adults.

Authors:  D H Van Thiel; R R Schade; T E Starzl; S Iwatsuki; B W Shaw; J S Gavaler; M Dugas
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

View more
  4 in total

Review 1.  Liver transplantation for primary biliary cirrhosis.

Authors:  A G Tzakis; C Carcassonne; S Todo; L Makowka; T E Starzl
Journal:  Semin Liver Dis       Date:  1989-05       Impact factor: 6.115

Review 2.  The assessment of body composition in patients with cirrhosis.

Authors:  M Y Morgan; A M Madden
Journal:  Eur J Nucl Med       Date:  1996-02

Review 3.  Liver transplantation (1).

Authors:  T E Starzl; A J Demetris; D Van Thiel
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

Review 4.  Liver transplantation and primary biliary cirrhosis.

Authors:  A K Burroughs; M Biagini; P A McCormick; K Rolles
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.